NexImmune (NEXI)
(Delayed Data from OTC)
$1.17 USD
0.00 (0.34%)
Updated Aug 12, 2024 10:31 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NEXI 1.17 0.00(0.34%)
Will NEXI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NEXI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NEXI
What Makes NexImmune, Inc. (NEXI) a New Buy Stock
Biotech Stock Roundup: APLS, NVAX Gain on Updates, INCYs Regulatory News & More
NEXI: What are Zacks experts saying now?
Zacks Private Portfolio Services
NexImmune (NEXI) IND Gets Clearance for HPV-Related Cancer Drug
What Makes NexImmune, Inc. (NEXI) a New Buy Stock
Other News for NEXI
Buy Rating Affirmed for Nexi S.p.A. on Strong Fundamentals and Positive Financial Outlook
Nexi S.p.A. (NEXI) Receives a Buy from Kepler Capital
GLOBAL BROKER RATINGS: Barclays raises Ferrari; Goldman cuts lululemon
Nexi S.p.A. (NEXI) Receives a Buy from UBS
Strong Q2 Performance and Strategic Initiatives Underpin Buy Rating for Nexi S.p.A.